Skip to main content
Equibles

Metis Global Partners, LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1594916 San Diego, CA
Back to REGN Full portfolio

Position in REGN

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$1,520,814
-$1,915,888 QoQ
Shares Held
2,439
-45.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#570
of 1,331 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Metis Global Partners, LLC holds $12,809,533 across 8 Biotechnology names. REGN ranks #3 (11.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 10,929 $5,428,762
2 RPRX
Royalty Pharma plc
 59,374 $3,329,100
3 REGN
Regeneron Pharmaceuticals, Inc.
This page 		2,439 $1,520,814
4 ALNY
Alnylam Pharmaceuticals, Inc.
 4,009 $1,206,829
5 INCY
Incyte Corp
 4,068 $461,148
6 MRNA
Moderna, Inc.
 6,452 $451,833
7 TECH
BIO-TECHNE Corp
 2,918 $206,156
8 PBYI
Puma Biotechnology, Inc.
 25,264 $204,891

All Filings in REGN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,520,814 2,439
2026-03-31 $3,436,702 4,448
2025-12-31 $3,728,903 4,831
2025-09-30 $2,929,988 5,211
2025-06-30 $2,885,925 5,497
2025-03-31 $4,000,088 6,307
2024-12-31 $3,927,075 5,513
2024-09-30 $5,617,826 5,344
2024-06-30 $5,522,111 5,254
2024-03-31 $5,036,710 5,233
2023-12-31 $4,589,943 5,226
2023-09-30 $4,501,591 5,470
2023-06-30 $3,431,747 4,776
2023-03-31 $3,856,097 4,693
2022-12-31 $2,953,058 4,093
2022-09-30 $2,034,921 2,954
2022-06-30 $1,688,267 2,856
2022-03-31 $1,444,332 2,068
2021-12-31 $822,870 1,303